Comparison of in vitro toxicity of silver ions and silver nanoparticles on human hepatoma cells

Environmental Toxicology

Volumn 31, Issue 6, 2016, Pages 679-692

  Vrček, Ivana Vinković ^a   Žuntar, Irena ^b   Petlevski, Roberta ^b   Pavičić, Ivan ^a   Dutour Sikirić, Maja ^c   Ćurlin, Marija ^d   Goessler, Walter ^e  

^a INSTITUTE FOR MEDICAL RESEARCH AND OCCUPATIONAL HEALTH   (Croatia)

^b UNIVERSITY OF ZAGREB   (Croatia)

^c RUDER BO KOVI INSTITUTE   (Croatia)

^d UNIVERSITY OF ZAGREB   (Croatia)

^e UNIVERSITY OF GRAZ   (Austria)

Author keywords

Cytotoxicity; HepG2 cells; Ionic silver; Oxidative stress; Silver nanoparticles

Indexed keywords

CELLS; CONSUMER PRODUCTS; CYTOLOGY; CYTOTOXICITY; METAL IONS; NANOPARTICLES; OXIDATIVE STRESS; RISK ASSESSMENT; TOXICITY;

DOSE-DEPENDENT MANNER; HEP-G2 CELLS; HUMAN HEPATOMA CELLS; OXIDATIVE STRESS MARKERS; SCIENTIFIC INFORMATION; SILVER NANOPARTICLES; SILVER NANOPARTICLES (AGNPS); TOXICITY MECHANISMS;

SILVER;

ALANINE AMINOTRANSFERASE; ALBUMIN; CITRIC ACID; GLUTATHIONE; LACTATE DEHYDROGENASE; REACTIVE OXYGEN METABOLITE; SILVER; SILVER NANOPARTICLE; SUPEROXIDE DISMUTASE; ALBUMINOID; ION; METAL NANOPARTICLE;

ANION; BIOMARKER; CELLS AND CELL COMPONENTS; DETOXIFICATION; DOSE-RESPONSE RELATIONSHIP; NANOPARTICLE; OXIDATION; SILVER; TOXICITY TEST;

ARTICLE; CELL FUNCTION; CELL VIABILITY; CONTROLLED STUDY; ENZYME ACTIVITY; HEPATOMA CELL; HEPG2 CELL LINE; HUMAN; HUMAN CELL; IC50; IN VITRO STUDY; LIVER CELL CARCINOMA; LIVER TOXICITY; MEMBRANE DAMAGE; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN DEPLETION; PROTEIN SYNTHESIS INHIBITION; CELL SURVIVAL; COMPARATIVE STUDY; DRUG EFFECTS; HEP-G2 CELL LINE; SECRETION (PROCESS);

ALBUMINS; CELL SURVIVAL; HEP G2 CELLS; HUMANS; IONS; METAL NANOPARTICLES; OXIDATIVE STRESS; SILVER;

EID: 84919458801     PISSN: 15204081     EISSN: 15227278     Source Type: Journal    
DOI: 10.1002/tox.22081     Document Type: Article

References (50)

1. Ahmad J, Alhadlaq HA, Siddiqui MA, Saquib Q, Al-Khedhairy AA, Musarrat J, Ahamed M. 2013. Concentration-dependent induction of reactive oxygen species, cell cycle arrest and apoptosis in human liver cells after nickel nanoparticles exposure. Environ Toxicol. doi: 10.1002/tox.21879.
2. AshaRani PV, Kah Mun GL, Prakash Hande M, Valiyaveettil S. 2009. Cytotoxicity and genotoxicity of silver nanoparticles in human cells. ACS Nano 3:279-290.
3. Auffan MV, Rose J, Wiesner MR, Bottero J-Y. 2009. Chemical stability of metallic nanoparticles: A parameter controlling their potential cellular toxicity in vitro. Environ Pollut 157:1127-1133.
4. Birringer M, Lington D, Vertuani S, Manfredini S, Schartau D, Glei M, Ristow M. 2010. Proapoptotic effects of long-chain vitamin E metabolites in HepG2 cells are mediated by oxidative stress. Free Rad Biol Med 49:1315-1322.
5. Bondarenko O, Juganson K, Ivask A, Kasemets K, Mortimer M, Kahru A. 2013. Toxicity of Ag, CuO and ZnO nanoparticles to selected environmentally relevant test organisms and mammalian cells in vitro: A critical review. Arch Toxicol 87:1181-1200.
6. Braydich-Stolle L, Hussain S, Schlager J, Canada TA, Wiencek KM, Cowan ME, Lindsay BJ. 2007. Challenging Silver-Influence of Extraction Medium on the Release of Silver from Commercial Silver Dressings. Spartanburg: Milliken & Company.
7. Cañamares MV, Garcia-Ramos JV, Sanchez-Cortes S, Castillejo M, Oujja M. 2008. Comparative SERS effectiveness of silver nanoparticles prepared by different methods: A study of the enhancement factor and the interfacial properties. J Colloid Inter Sci 326:103-109.
8. Carlson C, Hussain SM, Schrand AM, Braydich-Stolle LK, Hess KL, Jones RL, Schlager JJ. 2008. Unique cellular interaction of silver nanoparticles: Size-dependent generation of reactive oxygen species. J Phys Chem B 112:13608-13619.
9. Chakrabarti R, Kundu S, Kumar S. 2000. Vitamin A as an enzyme that catalyzes the reduction of MTT to formazan by vitamin C. J Cell Biochem 80:133-138.
10. Chen J, Rogers SC, Kavdia M. 2013. Analysis of kinetics of dihydroethidium fluorescence with superoxide using xanthine oxidase and hypoxanthine assay. Ann Biomed Eng 41:327-337.
11. Chen X, Zhong Z, Xu Z, Chen L, Wang Y. 2010. 2′, 7′-Dichlorodihydrofluorescein as a fluorescent probe for reactive oxygen species measurement: Forty years of application and controversy. Free Radic Res 44:587-604.
12. Christian P, Von der Kammer F, Baalousha M, Hofmann T. 2008. Nanoparticles: Preparation properties and behaviour in environmental media. Ecotoxicology 17:326-343.
13. Danscher G. 1981. Light and electron microscopic localisation of silver in biological tissue. Histochemistry 71:177-186.
14. Farkas J, Christian P, Gallego-Urrea JA, Roos N, Hassellov M, Tollefsen KE, Thomas KV. 2011. Uptake and effects of manufactured X nanoparticles in rainbow trout (Oncorhynchus mykiss) gill cells RID F-3693-2010. Aquat Toxicol 101:117-125.
15. Furchner JE, Richmond CR, Drake GA. 1968. Comparative metabolism of radionuclides in mammals-IV. Retention of silver-110 m in the mouse, rat, monkey, and dog. Health Phys 15:505-514.
16. Gaiser BK, Hirn S, Kermanizadeh A, Kanase N, Fytianos K, Wenk A, Haberl N, Brunelli A, Kreyling WG, Stone V. 2013. Effects of silver nanoparticles on the liver and hepatocytes in vitro. Toxicol Sci 131:537-547.
17. Gliga AR, Skoglund S, Wallinder IO, Fadeel B, Karlsson HL. 2014. Size-dependent cytotoxicity of silver nanoparticles in human lung cells: The role of cellular uptake, agglomeration and Ag release. Part Fibre Toxicol 11:11.
18. Greulich C, Diendorf J, Simon T, Eggeler G, Epple M, Koller M. 2011. Uptake and intracellular distribution of silver nanoparticles in human mesenchymal stem cells. Acta Biomater 7:347-354.
19. Han X, Gelein R, Corson N, Wade-Mercer P, Jiang J, Biswas P, Finkelstein JN, Elder A, Oberdörster G. 2011. Validation of an LDH assay for assessing nanoparticle toxicity. Toxicology 287:99-104.
20. Holder AL, Goth-Goldstein R, Lucas D, Koshland CP. 2012. Particle-induced artifacts in the MTT and LDH viability assays. Chem Res Toxicol 25:1885-1892.
21. Hussain SM, Hess KL, Gearhart JM, Geiss KT, Schlager JJ. 2005. In vitro toxicity of nanoparticles in BRL 3A rat liver cells. Toxicol In Vitro 19:975-983.
22. Kawata K, Osawa M, Okabe S. 2009. In vitro toxicity of silver nanoparticles at noncytotoxic doses to HepG2 human hepatoma cells. Environ Sci Technol 43:6046-6051.
23. Kehrer JP. 1993. Free radicals as mediators of tissue injury and disease. Crit Rev Toxicol 23:21-48.
24. Kim YS, Kim JS, Cho HS, Rha DS, Kim JM, Park JD, Choi BS, Lim R, Chang HK, Chung YH, Kwon IH, Jeong J, Han BS, Yu IJ. 2008. Twenty-eight-day oral toxicity, genotoxicity, and gender-related tissue distribution of silver nanoparticles in Sprague-Dawley rats. Inhal Toxicol 20:575-583.
25. Kroll A, Dierker C, Rommel C, Hahn D, Wohlleben W, Schulze-Isfort C, Gobbert C, Voetz M, Hardinghaus F, Schnekenburger J. 2011. Cytotoxicity screening of 23 engineered nanomaterials using a test matrix of ten cell lines and three different assays. Part Fibre Toxicol 8:1-9.
26. Larese FF, D'Agostin F, Crosera M, Adami G, Renzi N, Bovenzi M, Maina G. 2009. Human skin penetration of silver nanoparticles through intact and damaged skin. Toxicology 255:33-37.
27. Lee PC, Meisel D. 1982. Adsorption and surface-enhanced Raman of dyes on silver and gold sols. J Phys Chem 86:3391-3395.
28. Limbach LK, Wick P, Manser P, Grass RN, Bruinink A, Stark WJ. 2007. Exposure of engineered nanoparticles to human lung epithelial cells: Influence of chemical composition and catalytic activity on oxidative stress. Environ Sci Technol 41:4158-4163.
29. Liu J, Hurt RH. 2010. Controlled release of biologically active silver from nanosilver surfaces. Environ Sci Technol 44:2169-2175.
30. Liu W, Wu Y, Wang C, Li HC, Wang T, Liao CY, Cui L, Zhou QF, Yan B, Jiang GB. 2010. Impact of silver nanoparticles on human cells: Effect of particle size. Nanotoxicology 4:319-330.
31. Matés JM. 2000. Effects of antioxidant enzymes in the molecular control of reactive oxygen species. Toxicology 153:83-100.
32. Miyada DS, Baysinger V, Notrica S, Nakamura RM. 1972. Albumin quantitation by dye binding and salt fractionation techniques. Clin Chem 8:52-56.
33. Morones JR, Elechiguerra JL, Camacho A, Holt K, Kouri JB, Ramirez JT, Yacaman MJ. 2005. The bactericidal effect of silver nanoparticles. Nanotechnology 16:2346-2353.
34. Mosmann J. 1983. Rapid colorimetric assay for cellular growth and survival: Application to proliferation and cytotoxicity assays. J Immunol Methods 65:55-63.
35. Munro CH, Smith WE, Garner M, Clarkson J, White PC. 1995. Characterization of the surface of a citrate-reduced colloid optimized for use as a substrate for surface-enhanced resonance Raman scattering. Langmuir 11:3712-3720.
36. Park EJ, Yi J, Kim Y, Choi K, Park K. 2010. Silver nanoparticles induce cytotoxicity by a Trojan-horse type mechanism. Toxicol In Vitro 24:872-878.
37. Piao MJ, Kang KA, Lee IK, Kim HS, Choi YJ, Hyun JW. 2011. Silver nanoparticles induce oxidative cell damage in human liver cells through inhibition of reduced glutathione and induction of mitochondria-involved apoptosis. Toxicol Lett 201:92-100.
38. Reitman S, Frankel S. 1957. A colorimetric method for the determination of serum glutamic oxalacetic and glutamic pyruvic transaminases. Am J Clin Pathol 28:56-63.
39. Rothschild MA, Oratz M, Schreiber SS. 1988. Serum albumin. Hepatology 8:385-401.
40. Sahu SC, Zheng J, Graham L, Chen L, Ihrie J, Yourick JJ, Sprando RL. 2014. Comparative cytotoxicity of nanosilver in human liver HepG2 and colon Caco2 cells in culture. J Appl Toxicol 34:1155-1166.
41. Schrurs F, Lison D. 2012. Focusing the research efforts. Nat Nanotechnol 7:546-548.
42. Singh S, Nalwa HS. 2007. Nanotechnology and health safety-Toxicity and risk assessments of nanostructured materials on human health. J Nanosci Nanotechnol 7:3048-3070.
43. Šinko G, Vinković Vrček I, Goessler W, Leitinger G, Dijanošić A, Miljanić S. 2013. Alteration of cholinesterase activity as possible mechanism of silver nanoparticle toxicity. Environ Sci Pollut Res 21:1391-1400.
44. Stevenson D, Wokosin D, Girkin J, Grant MH. 2002. Measurement of the intracellular distribution of reduced glutathione in cultured rat hepatocytes using monochlorobimane and confocal laser scanning microscopy. Toxicol In Vitro 16:609-619.
45. Suliman YAO, Ali D, Alarifi S, Harrath AH, Mansour L, Alwasel SH. 2013. Evaluation of cytotoxic, oxidative stress, proinflammatory and genotoxic effect of silver nanoparticles in human lung epithelial cells. Environ Toxicol. doi: 10.1002/tox.21880.
46. Sung JH, Ji JH, Park JD, Yun JU, Kim DS, Jeon KS, Song MY, Jeong J, Han BS, Han JH, Chung YH, Chang HK, Lee JH, Cho MH, Kelman B, Yu IJ. 2009. Subchronic inhalation toxicity of silver nanoparticles. Toxicol Sci 108:452-461.
47. Sussman NL, Gislason GT, Conlin CA, Kelly JH. 1994. The hepatix extracorporeal liver assist device: Initial clinical experience. Artif Organs 18:390-396.
48. Walker M, Parsons D. 2014. The biological fate of silver ions following the use of silver-containing wound care products-A review. Int Wound J 11:496-504.
49. Wang Z, Li N, Zhao J, White JC, Qu P, Xing B. 2012. CuO nanoparticle interaction with human epithelial cells: Cellular uptake, location, export, and genotoxicity. Chem Res Toxicol 25:1512-1521.
50. Yu S-J, Chao J-B, Sun J, Yin Y-G, Liu J-F, Jiang G-B. 2013. Quantification of the uptake of silver nanoparticles and ions to HepG2 cells. Environ Sci Technol 47:3268-3274.